Schütt M, Benecke H, Drenckhan M, Klein H H
Department of Internal Medicine I, Medical University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.
Eur J Endocrinol. 2000 Jul;143(1):125-31. doi: 10.1530/eje.0.1430125.
To investigate the functional properties of insulin receptors with a Thr-->Ser(1200)-mutation that is associated with severe insulin resistance in humans.
The effect of in situ insulin-stimulation on insulin receptor kinase activity was studied in Chinese hamster ovary cells with overexpressed human Ser(1200)-mutated, non-mutated, and ATP-binding site-mutated (Lys-->Arg(1030)) receptors using a microwell-based assay that only detects human (and not hamster) insulin receptors. Moreover, the fraction of anti-phosphotyrosine antibody-binding receptors following in situ stimulation was separated, and autophosphorylation and kinase activity resulting from in situ and/or in vitro activation evaluated in this fraction.
Although insulin-stimulated kinase activity of human-specific anti-insulin receptor antibody-binding receptors in cells with Ser(1200)-mutated insulin receptors represented only 3.3% of that reached in cells with non-mutated receptors, a clear insulin-induced increase in kinase activity was observed (3.4-fold; P<0.05). This increase was associated with a 2.3+/-0.6% (P<0.05) increase in anti-phosphotyrosine-binding receptors with a kinase activity representing 43+/-8% of that found in activated non-mutated receptors. In vitro autophosphorylation and kinase activation proceeded much more slowly in Ser(1200)-mutated receptors (t(1/2)): 100 min) compared with non-mutated receptors (t(1/2)): 1 min) and were inhibitable by lower alkaline phosphatase concentrations (EC(50): 3 U/ml and 70 U/ml respectively). No activation of insulin receptor kinase was observed with Arg(1030)-mutated receptors.
Overexpressed Ser(1200)-mutated human insulin receptors possess insulin-stimulated kinase activity and can be activated in situ and in vitro. They are characterized by a markedly slower autophosphorylation reaction, which, in a phosphatase-containing environment, results in a small fraction of phosphorylated and activated receptors.
研究具有苏氨酸→丝氨酸(1200)突变的胰岛素受体的功能特性,该突变与人类严重胰岛素抵抗相关。
利用基于微孔板的检测方法,该方法仅检测人(而非仓鼠)胰岛素受体,研究原位胰岛素刺激对过表达人丝氨酸(1200)突变、未突变及ATP结合位点突变(赖氨酸→精氨酸(1030))受体的中国仓鼠卵巢细胞中胰岛素受体激酶活性的影响。此外,分离原位刺激后抗磷酸酪氨酸抗体结合受体的比例,并评估该部分中由原位和/或体外激活产生的自磷酸化和激酶活性。
尽管在具有丝氨酸(1200)突变胰岛素受体的细胞中,人特异性抗胰岛素受体抗体结合受体的胰岛素刺激激酶活性仅为未突变受体细胞中达到活性的3.3%,但仍观察到胰岛素诱导的激酶活性明显增加(3.4倍;P<0.05)。这种增加与抗磷酸酪氨酸结合受体增加2.3±0.6%(P<0.05)相关,其激酶活性为激活的未突变受体中激酶活性的43±8%。与未突变受体(半衰期:1分钟)相比,丝氨酸(1200)突变受体的体外自磷酸化和激酶激活过程要慢得多(半衰期:100分钟),并且较低浓度的碱性磷酸酶(分别为EC50:3 U/ml和70 U/ml)即可抑制。精氨酸(1030)突变受体未观察到胰岛素受体激酶的激活。
过表达的丝氨酸(1200)突变人胰岛素受体具有胰岛素刺激的激酶活性,可在原位和体外被激活。其特征是自磷酸化反应明显较慢,在含有磷酸酶的环境中,导致只有一小部分受体被磷酸化和激活。